Back
Sage Therapeutics Vs. Finch Therapeutics Group Industry Stock Comparison
Sell
30
SAGE
Sage Therapeutics
Last Price:
13.26
Seasonality Move:
1%
Sell
22
FNCH
Finch Therapeutics Group
Last Price:
2.28
Seasonality Move:
-20.22%
Sell
30
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $13.94. The Score for SAGE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Finch Therapeutics Group (FNCH)
is a Sell
Is Finch Therapeutics Group a Buy, Sell or Hold?
- The current Finch Therapeutics Group [FNCH] share price is $2.30. The Score for FNCH is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- FNCH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $13.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
FNCH Stock Price Chart
What is Finch Therapeutics Group's stock price today?
-
The Finch Therapeutics Group share price today is $2.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FNCH is experiencing selling pressure, which indicates risk of future bearish movement.
SAGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.25 | Sell |
Relative Strength Index (14 RSI): | 40.02 | Sell |
Chaikin Money Flow: | 792027 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.25 - 16.55) | Sell |
Bollinger Bands (100): | (16.7 - 24.88) | Sell |
FNCH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 47.53 | Sell |
Chaikin Money Flow: | -37657 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.18 - 2.58) | Sell |
Bollinger Bands (100): | (2.35 - 3.21) | Sell |
SAGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.71 | Buy |
20-day SMA: | 14.35 | Sell |
50-day SMA: | 17.76 | Sell |
200-day SMA: | 21.42 | Sell |
8-day EMA: | 13.69 | Buy |
20-day EMA: | 14.58 | Sell |
50-day EMA: | 17.09 | Sell |
200-day EMA: | 23.58 | Sell |
FNCH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Sell |
20-day SMA: | 2.38 | Sell |
50-day SMA: | 2.51 | Sell |
200-day SMA: | 4.11 | Sell |
8-day EMA: | 2.35 | Sell |
20-day EMA: | 2.39 | Sell |
50-day EMA: | 2.53 | Sell |
200-day EMA: | 7.15 | Sell |
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.15 per share, an increase this year of $3.05 per share, and an increase next year of $1.02 per share.
Finch Therapeutics Group Earnings Growth & FNCH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $29.13 per share, and a decrease next year of $0.00 per share.
Sage Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Finch Therapeutics Group Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |